Drug Pipeline

meropenem Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
4
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-11 NCT07641348 COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT… Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07556107 The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) Infection Not Yet Recruiting
Phase 2
NCT04886284 Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus… Staphylococcus Aureus Bacteremia Recruiting
NCT07318584 Cefotetan Therapy for Escherichia Coli Infections E Coli Infection Not Yet Recruiting
Not specified
NCT07641348 COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT… Typhoid Fever Not Yet Recruiting
Sponsors Running meropenem Trials
Todd C. Lee MD MPH FIDSA (1) Oregon Health and Science University (1) Bassett Healthcare (1) Iqra Asghar Ali (1)
Get alerts when meropenem trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free